Skip to main content

Table 5 Multivariate analysis comparing survival in subgroups of patients with de novo MBC stratified by both clinicopathologic and treatment-related characteristics

From: Impact of modern chemotherapy on the survival of women presenting with de novo metastatic breast cancer

Characteristic

Hazard ratio

95% CI

P-value

Category

   

 A

1.00

reference

0.76

 A + B

1.04

0.77 – 1.40

 

Age

   

 <50

1.00

reference

0.0008

 ≥50

1.61

1.23 – 2.20

 

AI

   

 No

1.00

reference

0.0008

 Yes

0.50

0.34 – 0.75

 

Zoledronic acid

   

 No

1.00

reference

0.005

 Yes

0.45

0.26 – 0.79

Â